Search results
Darren Hickling describes NHS Digital’s role in developing a platform to identify the highest risk COVID-19 patients so they could receive life-saving antiviral treatments.
At the height of the pandemic, NHS Digital took the decision to migrate the COVID-19 National Testing Service to a new platform. Mark Byrne, Head of Technology, explains how the team succeeded in doing this while processing about 1 million test results per day – without anyone really noticing.
A small group from NHSX, NHS Digital, NHS Business Services Authority and the Behavioural Insights Team has developed a text service for those most threatened by COVID-19.
This is a release of management information about patients previously identified as clinically extremely vulnerable (CEV) and at high risk of death from coronavirus (COVID-19) who were on the Shielded Patient List (SPL).
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.